Clinical trials
Phase 2 Optic Neuritis trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
16 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2008 | 1 |
| 2009 | 1 |
| 2010 | 2 |
| 2011 | 2 |
| 2012 | 1 |
| 2013 | 2 |
| 2017 | 4 |
| 2021 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 7 |
| Terminated | 5 |
| Recruiting | 2 |
| Unknown status | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University of Calgary | 2 |
| Anastasia Vishnevetsky, MD, MPH | 1 |
| Biogen | 1 |
| Daval International Limited | 1 |
| EMD Serono | 1 |
| First Affiliated Hospital of Guangxi Medical University | 1 |
| Friedemann Paul | 1 |
| Institut fuer anwendungsorientierte Forschung und klinische Studien GmbH | 1 |
| Isfahan University of Medical Sciences | 1 |
| Novartis Pharmaceuticals | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Optic Neuritis | 16 |
| Multiple Sclerosis | 7 |
| Eye Pain | 1 |
| Multiple Sclerosis, Chronic Progressive | 1 |
| Neuritis | 1 |
| Neuromyelitis Optica | 1 |
| Vision Disorders | 1 |
Trials
Showing 51 to 16 of 16. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.